
Valoe and Simoldes Have Signed the Second Phase of the Project for Development of a Solar Car Roof Prototype for a Stellantis Model
Valoe Corporation Inside information 7 March 2023 at 11.05 (Finnish time)
Valoe Oyj and Simoldes Plásticos S.A., a Portuguese company and an existing production partner of Stellantis and other European car manufacturers, have signed the second phase project under the existing Joint Development Agreement signed in 2021, for design, development and prototyping of a photovoltaic car roof for Stellantis. The second phase includes a prototype of an industrialized solar car roof for a specific model. The partners expect this stage to be ready during the third quarter of 2023 and work together towards automatized production technologies to allow for high-cadency mass production of solar roofs.
A full-scale car roof will be manufactured and integrated in a demo car, fully functional and able to generate power to charge the EV battery. Subject to successful completion of the second phase the parties intend to pursue the manufacturing and supply of vehicle-integrated photovoltaic car roofs and related technology transfer.
Júlio Grilo, Research and Innovation Head of Simoldes Plásticos S.A.: ”Simoldes recognizes the great achievements with the results of the first phase and is now ready to continue to invest in the second phase as part of our company strategy to invest in sustainable mobility solutions. We see the value of working with Valoe, a highly specialized company in this sector. Valoe also shares our vision and has been a most cooperative partner for us. By joining our skills and efforts, together, we will be able to create a new type of photovoltaic car roofs and to correspond e.g. to major OEMs requirements. We believe that such a product will be in high demand by all major car manufacturers in the next coming years”.
Iikka Savisalo, Valoe’s CEO: “It is rewarding to see the progress we have made together with Simoldes during our first phase and we are very happy with the results achieved. We have made a long jump towards the overall goal of manufacturing integrated solar car parts in partnership with Simoldes. Valoe believes its flexible back contact technology and the powerful IBC back contact cells are the reasons for being selected as the technology provider by such remarkable and prominent company as Simoldes. We estimate that the cooperation with Simoldes will lead to a significant increase in Valoe's turnover from next year onwards.”
SimoldesPlásticos S.A. is a Portuguese company, subsidiary of Simoldes Group, with 22 manufacturing sites in 13 different countries. Simoldes is Europe's largest mould maker, supplying plastic injection moulds and plastic components for the automotive industry. Simoldes Group’s main customers are worldwide automotive manufacturers like Stellantis (Peugeot, Citröen, DS Automobiles, Opel, Fiat, Chrysler, Jeep, Alfa Romeo), Renault, Porsche, BMW, Mercedes-Benz, Volkswagen and Audi.https://www.simoldes.com/en/plastics/
Valoe is an innovative technology company based in Finland that operates in the clean energy business. The company’s objective is to have clean solar electricity available for everyone everywhere. Valoe’s solar module plant is located inJuva, Finland, and the company has an IBC solar cell plant in Vilnius, Lithuania.
In Mikkeli 7 March 2023
Valoe Corporation
Board of Directors
For more information: Iikka Savisalo
President and CEO, Valoe Corporation
Tel. +358 40 521 6082, email: iikka.savisalo@valoe.com
Distribution:
NASDAQ OMX, Helsinki
Main media
www.valoe.com
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
TRESU Investment Holding A/S – Registration for investor call28.3.2023 11:04:29 CEST | Press release
TRESU INVESTMENT HOLDING A/S ANNOUNCEMENT NO. 02.2023 28.03.2022 TRESU Investment Holding A/S is pleased to invite you to the financial results call, which is being held: Wednesday, 5 April 2022, at 11am CET. The Annual Report will be presented by Christian Jacob Flarup, CEO and Torben Børsting, CFO. After the presentation there will be an opportunity for Q+A. A recording of the results call will be made available for four hours on the TRESU IR website. To register for the investor call, please send an e-mail to Financial manager at TRESU A/S Finn Holm no later than 4 April 2023 9am CET - fho@tresu.com Christian Jacob Flarup CEO, TRESU For further details, please contact: CEO, Christian Jacob Flarup, phone: +45 2027 7971 CFO, Torben Børsting, phone: +45 5130 2780 Attachment Quarterly reporting - Call - 2022 Q4
Alvotech Provides Update on Corporate Sustainability Framework28.3.2023 11:00:00 CEST | Press release
Alvotech (Nasdaq: ALVO) (the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced an update to the Company’s Corporate Sustainability framework, including the release of key environmental, social and governance (“ESG”) indicators for 2022. “As part of our commitment to improve the sustainability of healthcare by providing access to more affordable biologic medicines, we recognize that corporate sustainability is closely linked to our long-term success and the value we may bring to patients, healthcare providers and all of our stakeholders,” said Robert Wessman, Founder, Chairman and CEO of Alvotech. Data on key ESG indicators for 2020-2022 can be found on Alvotech’s dedicated web portal. Alvotech’s Board of Directors has established a Corporate Sustainability Committee (CSC) to oversee the Company’s strategy as it relates to ESG matters. Alvotech’s corporate headquarters, purpose-built manuf
Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP839628.3.2023 10:54:21 CEST | Press release
Company announcement – No. 7 / 2023 Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP8396 Dose-dependent body weight reductions of up to a mean of 4.2% from baseline (4.8% placebo corrected) following a single dose of ZP8396In development as a non-incretin peptide therapyfor the potential management of overweight and obesity Copenhagen, Denmark, March 28, 2023 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. 20045078) a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced Phase 1a results for ZP8396, the company’s amylin analogue. The first-in-human study was designed to assess safety, pharmacokinetic (PK) and pharmacodynamic effects of ZP8396 in healthy lean and overweight people. “We are excited by the potential of amylin as an alternative, non-incretin treatment for overweight and obesity, and are very encouraged that treatment with a single dose of ZP8396 led to meaningful dose
Indkaldelse til ordinær generalforsamling i SKAKO A/S28.3.2023 10:50:52 CEST | pressemeddelelse
Til NASDAQ OMX Copenhagen A/S GlobeNewswire Faaborg, den 28. marts 2023 Selskabsmeddelelse nr. 5/2023 Indkaldelse til ordinær generalforsamling i SKAKO A/S SKAKO A/S indkalder til ordinær generalforsamling i selskabet til afholdelse onsdag den 19. april 2023, kl. 15.00 på selskabets adresse. Indkaldelsen er sket jf. selskabets vedtægter § 7 og er tilgængelig på selskabets hjemmeside. Udbytte På baggrund af det stærke resultat i 2022 og kapitalstrukturen i SKAKO A/S pr. 31. december 2022 anbefaler bestyrelsen en udbytteudlodning på DKK 5 pr. aktie svarende til 61,0% af årets resultat og en samlet udbytteudlodning på DKK 15,4 mio. Med en aktiekurs på 62,6 kr. pr. 31. december 2022 svarer det til en udbytteprocent på 8,0%. Udbyttebetalingen vil være et behandlingspunkt på agendaen for den ordinære generalforsamling 19. april 2023. Ex-udbytte dato: 19. april 2023 Optagelsesdato: 20. april 2023 Udbetalingsdato: 24. april 2023 Med venlig hilsen SKAKO A/S Jens Wittrup Willumsen Bestyrelsesfor
Aalborg Boldspilklub A/S indkalder til ordinær generalforsamling28.3.2023 10:50:49 CEST | pressemeddelelse
NASDAQ Copenhagen A/S Børsmeddelelse nr. 2023/06 Aalborg, 28. marts 2023 Vedhæftet indkaldelse og dagsorden til ordinær generalforsamling i Aalborg Boldspilklub A/S onsdag 19. april 2023 kl. 16.00 på Aalborg Portland Park. Venlig hilsen Aalborg Boldspilklub A/S Thomas Bælum Administrerende direktør For yderligere oplysninger: Thomas Bælum 2251 7901 Vedhæftede filer Dagsorden 2023 - Inkl Bilag A og Bilag BAAB_ Brevstemme blanket_GF2023_v5